Royal Bank Of Canada Bridge Bio Pharma, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 20,305 shares of BBIO stock, worth $590,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,305

Previous 18,692 8.63%

Holding current value

$590,469

Previous $473,000 9.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $38,566 - $50,486	1,613 Added 8.63%	20,305 $516,000
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $265,972 - $358,946	11,564 Added 162.23%	18,692 $473,000
Q1 2024 Nov 05, 2024	SELL	$27.35 - $40.45 $316,275 - $467,763	-11,564 Reduced 61.87%	7,128 $220,000
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $899,240 - $1.33 Million	-32,879 Reduced 82.18%	7,128 $220,000
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $498,366 - $910,629	20,748 Added 107.73%	40,007 $1.62 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $34,489 - $71,490	-2,042 Reduced 9.59%	19,259 $507,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $79,115 - $107,213	-5,953 Reduced 21.84%	21,301 $366,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $50,261 - $130,035	7,010 Added 34.63%	27,254 $451,000
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $41,100 - $70,248	6,098 Added 43.11%	20,244 $154,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $52,880 - $82,317	-6,660 Reduced 32.01%	14,146 $141,000
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $521 - $1,214	100 Added 0.48%	20,806 $189,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $91,471 - $213,847	-12,462 Reduced 37.57%	20,706 $210,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $279,071 - $1.31 Million	24,523 Added 283.67%	33,168 $553,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $23,247 - $31,863	-496 Reduced 5.43%	8,645 $405,000
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $424,782 - $584,384	9,141 New	9,141 $557,000

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Bridge Bio Pharma, Inc. Transaction History